NIMH seeks applications for research projects to evaluate the effectiveness of service-ready tools and technologies that can be used to advance training, quality monitoring, and quality improvement efforts and ultimately improve the availability of evidence-based suicide prevention services. Specifically, this initiative encourages research on the effectiveness-implementation continuum aimed at (1) developing and testing the effectiveness of optimized, service-ready suicide prevention tools for identification, prevention, and treatment of individuals at risk for suicide; and (2) testing strategies to improve adoption, implementation fidelity, and sustained use of these tools, guided by an implementation science framework. Given the focus on practice-ready accessible resources and products that could be readily integrated into practice, NIMH encourages the use of technology and other design features that make the tools scalable and robust against implementation drift, and a deployment-focused approach that takes into account the perspectives of key stakeholders (e.g., service users, providers, administrators) and system-level factors, such as workforce capacity that influence potential integration of tools into clinical workflows.
This Funding Opportunity Announcement (FOA) is intended to support effectiveness research of service-ready tools and technologies for suicide prevention that are statistically powered to provide a definitive answer regarding the study tool’s effectiveness. Support for pilot effectiveness research to evaluate the initial feasibility, tolerability, acceptability, safety, and preliminary indications of effectiveness of service-ready tools and technologies for suicide prevention is provided via the R34 in RFA-MH-21-111. Support for SBIR studies focused on service-ready tools and technologies or suicide prevention is provided via the R43/R44 in RFA-MH-21-112.
Companion Funding Opportunities:
RFA-MH-21-111– Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional)
RFA-MH-21-112 – Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional)
The rate of death by suicide in the United States has increased each year since 2005, from 11.0/100,000 to 14.8/100,000 of the population in 2018. Distinct subgroups have experienced even greater increases in the rate of suicide deaths during this period. With an estimated 20 suicide attempts per death by suicide, and millions of people seriously considering and/or making plans for death by suicide each year, the cumulative toll on public health is enormous. Simultaneously, the field of suicide prevention research has seen unprecedented growth during the past decade, with sustained investment in research and health-system changes by both federal and non-profit organizations that provide hope for reducing the annual suicide rate if evidence-bases strategies can be widely implemented and sustained.
Consistent with the goals of the National Action Alliance for Suicide Prevention, NIMH seeks to support research on strategies that could be used to reduce the rate of suicide in the US by 20% by 2025. To realize this goal, it is imperative that suicide prevention strategies be brought to scale at a level not seen before. There is a chasm between what research has demonstrated are useful strategies for suicide prevention and what is often delivered in healthcare systems. To bridge this gap and aid in the systematic implementation of evidenced-based suicide prevention services, the NIMH seeks to fund research on service-ready tools for identification, prevention, and treatment of individuals at risk for suicide.
URL for more information:
Filed Under: Funding Opportunities